Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis

被引:187
作者
Caulfield, Michael P. [1 ]
Li, Shuguang [1 ]
Lee, Gloria [1 ]
Blanche, Patricia J. [2 ]
Salarneh, Wael A. [1 ]
Benner, W. Henry [3 ]
Reitz, Richard E. [1 ]
Krauss, Ronald M. [2 ]
机构
[1] Quest Diagnost Nichols Inst, San Juan Capistrano, CA 92675 USA
[2] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
[3] Lawrence Livermore Natl Lab, Livermore, CA USA
关键词
D O I
10.1373/clinchem.2007.100586
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
BACKGROUND: Current methods for measuring the concentrations of lipoprotein particles and their distributions in particle subpopulations are not standardized. We describe here and validate a new gas-phase differential electrophoretic macromolecular mobility-based method (ion mobility, or IM) for direct quantification of lipoprotein particles, from small, dense HDL to large, buoyant, very-low-density lipoprotein (VLDL). METHODS: After an ultracentrifugation step to remove albumin, we determined the size and concentrations of lipoprotein particles in serum samples using IM. Scan time is 2 min and covers a particle range of 17.2-540.0 A. After scanning, data are pooled by totaling the particle number across a predetermined size range that corresponds to particular lipoprotein subclasses. IM results were correlated with those of standard methods for cholesterol and apolipoprotein analysis. RESULTS: Intra- and interassay coefficients of variation for LDL particle size were < 1.0%. The intra- and interassay variation for LDL and HDL particle subfiraction measurements was <20%. IM-measured non-HDL correlated well with apolipoprotein B (r = 0.92). CONCLUSIONS: The IM method provides accurate, reproducible, direct determination of size and concentration for a broad range of lipoprotein particles. Use of this methodology in studies of patients with cardiovascular disease and other pathologic states will permit testing of its clinical utility for risk assessment and management of these conditions. (C) 2008 American Association for Clinical Chemistry.
引用
收藏
页码:1307 / 1316
页数:10
相关论文
共 23 条
[1]
ARMBRUSTER DA, 1994, CLIN CHEM, V40, P1233
[2]
LpA-1, LpA-I:A-II HDL and CHD-risk:: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial [J].
Asztalos, Bela F. ;
Demissie, Serkalem ;
Cupples, L. Adrienne ;
Collins, Dorothea ;
Cox, Caitlin E. ;
Horvath, Katalin V. ;
Bloomfield, Hanna E. ;
Robins, Sander J. ;
Schaefer, Ernst J. .
ATHEROSCLEROSIS, 2006, 188 (01) :59-67
[3]
Charge-reduced nano electrospray ionization combined with differential mobility analysis of peptides, proteins, glycoproteins, noncovalent protein complexes and viruses [J].
Bacher, G ;
Szymanski, WW ;
Kaufman, SL ;
Zöllner, P ;
Blaas, D ;
Allmaier, G .
JOURNAL OF MASS SPECTROMETRY, 2001, 36 (09) :1038-1052
[4]
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel [J].
Barter, PJ ;
Ballantyne, CM ;
Carmena, R ;
Cabezas, MC ;
Chapman, MJ ;
Couture, P ;
De Graaf, J ;
Durrington, PN ;
Faergeman, O ;
Frohlich, J ;
Furberg, CD ;
Gagne, C ;
Haffner, SM ;
Humphries, SE ;
Jungner, I ;
Krauss, RM ;
Kwiterovich, P ;
Marcovina, S ;
Packard, CJ ;
Pearson, TA ;
Reddy, KS ;
Rosenson, R ;
Sarrafzadegan, N ;
Sniderman, AD ;
Stalenhoef, AF ;
Stein, E ;
Talmud, PJ ;
Tonkin, AM ;
Walldius, G ;
Williams, KMS .
JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) :247-258
[5]
BENNER HW, 2007, Patent No. 7259018
[6]
Metabolic origins and clinical significance of LDL heterogeneity [J].
Berneis, KK ;
Krauss, RM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1363-1379
[7]
CHARACTERIZATION OF HUMAN HIGH-DENSITY LIPOPROTEINS BY GRADIENT GEL-ELECTROPHORESIS [J].
BLANCHE, PJ ;
GONG, EL ;
FORTE, TM ;
NICHOLS, AV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (03) :408-419
[8]
*CDCP, 2007, HEART DIS
[9]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[10]
History of electrical aerosol measurements [J].
Flagan, RC .
AEROSOL SCIENCE AND TECHNOLOGY, 1998, 28 (04) :301-380